IXUS vs SCHE: Which International ETF Is the Better Buy in 2026?

IXUS (iShares Core MSCI Total International Stock ETF) vs. SCHE (Schwab Emerging Markets Equity ETF): IXUS has a slightly higher expense ratio (0.07% vs 0.06%) but offers higher 1-year total return (25.86% vs 23.89%), higher dividend yield (2.94% vs 2.66%), and lower 5-year max drawdown (30.0% vs 31.4%). Portfolio risk appears lower as well with beta of 0.78 for IXUS vs 0.59 for SCHE, though SCHE is more concentrated in Asia (e.g., Taiwan 33%, mainland China 26%, India 16%). Despite SCHE’s emerging-markets tilt, the article’s performance comparison shows IXUS beating SCHE across multiple horizons (1-year and 3/5/10-year).

Analysis

The key market mechanism here is not “international vs emerging markets” in the abstract, but concentration risk versus diversification. SCHE behaves like a leveraged bet on a narrow Asia stack — Taiwan semis plus China internet — so its return path is much more sensitive to geopolitics, export controls, and local policy than the label suggests. IXUS is the cleaner de-risking vehicle because it blends developed-market cash flows, which usually means better earnings quality and less regime risk when the dollar strengthens or global growth slows.

Second-order, the headline winner from SCHE ownership is really TSM, while the biggest hidden losers are the China internet names sitting under the surface. That means any “emerging markets will outperform” view is only right if AI capex keeps the semiconductor complex bid while China policy stays benign; otherwise the ETF’s concentration can turn a macro call into a single-country risk event. IXUS also has a better chance of benefiting from rotation into financials and industrials outside the U.S., where capital returns and balance-sheet discipline matter more than top-line growth.

Near term, there is no obvious fundamental catalyst from the comparison itself; this is mostly a flows and factor-trade issue over days to weeks. Over 1-3 months, the main driver is likely USD direction and risk appetite; over 6-18 months, geopolitics around Taiwan and China is the larger asymmetry. The contrarian point: the market often assumes EM exposure is the higher-growth trade, but in practice SCHE is more of a semis proxy with a China overhang, so the “growth premium” can be overstated while the tail risk is understated.